this invention relates to the treatment of erectile dysfunction with a combination of a compound selected from potassium channel openers , and a compound selected from compounds which elevate cgmp levels . sildenafil or a pharmaceutically acceptable salt thereof is preferred as the cgmp pde elevator . also included are compositions and kits comprising such impotence treating compounds .